Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1

Interventions

Cyclophosphamide 75fludarabine phosphate 73Peripheral Blood Stem Cell Transplantation 59Mycophenolic Acid 53Tacrolimus 51Whole-Body Irradiation 48Busulfan 42Antilymphocyte Serum 40Cyclosporine 38Filgrastim 32fludarabine 31Methotrexate 30Melphalan 29Radiotherapy 22Methylprednisolone 18Cord Blood Stem Cell Transplantation 17Etoposide 16Sirolimus 14Alemtuzumab 13Flow Cytometry 12Cyclosporins 12thymoglobulin 11Granulocyte Colony-Stimulating Factor 11Cytarabine 10Psychiatric Rehabilitation 9sargramostim 8Thiotepa 8Rituximab 8Therapeutics 7Stem Cell Transplantation 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Myeloproliferative Disorders × balixafortide × Lymphoid × Clear all
NCT01413568 2016-02-26

Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies

Polyphor Ltd.

Phase 1/2 Completed
38 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡